Header Logo

Richard Swanson

Concepts (217)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
9
2018
331
1.980
Why?
Neuroendocrine Tumors
3
2018
21
0.820
Why?
Pancreatectomy
5
2017
96
0.690
Why?
Pancreaticoduodenectomy
3
2018
62
0.650
Why?
Liver Neoplasms
3
2017
277
0.630
Why?
Carcinoid Tumor
2
2017
12
0.630
Why?
Metastasectomy
1
2018
4
0.620
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2017
406
0.510
Why?
Esophageal Neoplasms
2
2016
77
0.480
Why?
Hospitals, Low-Volume
1
2014
17
0.460
Why?
Hospitals, High-Volume
1
2014
32
0.450
Why?
Pancreatic Cyst
2
2012
24
0.400
Why?
Pyloric Stenosis
1
2012
4
0.390
Why?
Esophagoscopy
1
2012
24
0.390
Why?
Esophagectomy
2
2012
45
0.390
Why?
Dendritic Cell Sarcoma, Follicular
1
2011
1
0.390
Why?
Catheterization
1
2012
111
0.370
Why?
Survival Rate
7
2018
802
0.370
Why?
General Surgery
2
2012
191
0.370
Why?
Catheter Ablation
2
2017
145
0.340
Why?
Advisory Committees
1
2010
108
0.330
Why?
Middle Aged
22
2018
16310
0.330
Why?
Lymph Nodes
2
2017
214
0.330
Why?
Neoplasm Staging
8
2017
452
0.300
Why?
Biopsy, Fine-Needle
1
2008
61
0.300
Why?
Rectal Neoplasms
2
2012
98
0.280
Why?
Aged
18
2018
13412
0.280
Why?
Colonic Neoplasms
2
2012
215
0.270
Why?
Male
24
2018
27727
0.260
Why?
Aged, 80 and over
11
2017
5128
0.240
Why?
Proportional Hazards Models
4
2018
674
0.240
Why?
Decision Making
1
2008
394
0.230
Why?
Neoplasm Recurrence, Local
3
2017
299
0.230
Why?
Humans
30
2018
59282
0.220
Why?
Liver Cirrhosis
1
2005
162
0.220
Why?
Female
23
2018
30695
0.220
Why?
Carcinoma, Hepatocellular
1
2005
168
0.220
Why?
Adult
13
2018
15663
0.210
Why?
Hepatectomy
2
2017
60
0.200
Why?
Stomach Neoplasms
2
2017
69
0.190
Why?
United States
7
2018
7385
0.190
Why?
Adenocarcinoma
3
2017
323
0.190
Why?
Kaplan-Meier Estimate
3
2018
396
0.190
Why?
Esophagogastric Junction
2
2017
15
0.180
Why?
Palliative Care
1
2002
215
0.170
Why?
Patient Selection
1
2002
464
0.170
Why?
Postoperative Complications
4
2016
1202
0.160
Why?
Combined Modality Therapy
2
2017
355
0.160
Why?
Treatment Outcome
7
2017
5283
0.160
Why?
Chemoradiotherapy
2
2016
49
0.160
Why?
Pancreas
2
2017
147
0.160
Why?
Neoadjuvant Therapy
2
2016
72
0.150
Why?
Prognosis
6
2017
1599
0.150
Why?
Follow-Up Studies
7
2017
2337
0.150
Why?
Neoplasm Metastasis
1
2018
188
0.150
Why?
Chemoradiotherapy, Adjuvant
1
2017
9
0.140
Why?
Fluorouracil
2
2017
55
0.140
Why?
Clinical Competence
1
2002
682
0.140
Why?
Lymph Node Excision
1
2017
38
0.140
Why?
Retrospective Studies
9
2016
6071
0.140
Why?
Cyclooxygenase 2 Inhibitors
1
2016
36
0.130
Why?
Carcinoma, Pancreatic Ductal
1
2017
106
0.130
Why?
Failure to Thrive
1
2016
7
0.130
Why?
Dehydration
1
2016
15
0.130
Why?
Transitional Care
1
2016
25
0.130
Why?
Cathepsin L
1
2015
21
0.130
Why?
Postoperative Care
1
2016
114
0.120
Why?
Endoscopy, Gastrointestinal
1
2015
68
0.120
Why?
Th17 Cells
1
2015
57
0.120
Why?
Gallbladder Neoplasms
2
2006
16
0.120
Why?
Intraoperative Complications
2
2013
85
0.120
Why?
Endoscopy, Digestive System
2
2015
25
0.120
Why?
Cell Cycle
1
2017
382
0.120
Why?
Pancreatitis
1
2015
95
0.120
Why?
Cysteine Endopeptidases
1
2015
91
0.120
Why?
Video Recording
2
2012
126
0.120
Why?
Gene Expression Regulation, Neoplastic
1
2017
475
0.110
Why?
Postoperative Period
1
2014
127
0.110
Why?
Lymphatic Metastasis
3
2017
74
0.110
Why?
Protein Processing, Post-Translational
1
2015
256
0.110
Why?
Photons
1
2013
26
0.110
Why?
Deoxycytidine
1
2013
40
0.110
Why?
Antimetabolites, Antineoplastic
1
2013
39
0.110
Why?
Risk Factors
4
2017
4982
0.110
Why?
Databases, Factual
2
2014
813
0.110
Why?
Gastric Outlet Obstruction
1
2012
2
0.100
Why?
Pylorus
1
2012
10
0.100
Why?
Barium Sulfate
1
2012
18
0.100
Why?
Retreatment
1
2012
46
0.100
Why?
Operating Rooms
1
2012
55
0.100
Why?
Vincristine
1
2011
25
0.100
Why?
Patient Readmission
1
2016
420
0.090
Why?
Cyclophosphamide
1
2011
75
0.090
Why?
Prednisone
1
2011
85
0.090
Why?
Doxorubicin
1
2011
97
0.090
Why?
Diffusion Magnetic Resonance Imaging
1
2012
145
0.090
Why?
Education, Medical, Continuing
1
2012
95
0.090
Why?
Pancreaticojejunostomy
1
2010
5
0.090
Why?
MicroRNAs
1
2017
616
0.090
Why?
Pancreatic Ducts
1
2010
30
0.090
Why?
Surgery Department, Hospital
1
2010
20
0.090
Why?
Disease-Free Survival
3
2017
228
0.090
Why?
Congresses as Topic
1
2010
73
0.090
Why?
Radiography
1
2012
516
0.090
Why?
Needles
1
2010
65
0.080
Why?
Cell Differentiation
1
2015
1298
0.080
Why?
Diabetes Mellitus
1
2014
515
0.080
Why?
Contrast Media
1
2012
408
0.080
Why?
Safety Management
1
2010
137
0.080
Why?
Cystadenoma, Papillary
1
2008
1
0.080
Why?
Time Factors
2
2014
3614
0.080
Why?
Cystadenoma, Mucinous
1
2008
5
0.080
Why?
Adenocarcinoma, Papillary
1
2008
9
0.080
Why?
Carcinoma, Neuroendocrine
1
2008
11
0.080
Why?
Endosonography
1
2008
26
0.080
Why?
Adenocarcinoma, Mucinous
1
2008
30
0.080
Why?
Pancreatic Diseases
1
2008
39
0.080
Why?
Adolescent
3
2014
5822
0.080
Why?
Societies, Medical
1
2010
335
0.070
Why?
Hematologic Neoplasms
1
2008
44
0.070
Why?
Graft vs Host Disease
1
2008
105
0.070
Why?
Cisplatin
2
2017
119
0.070
Why?
Databases as Topic
1
2006
52
0.070
Why?
Liver Function Tests
1
2005
36
0.060
Why?
Hematopoietic Stem Cell Transplantation
1
2008
328
0.060
Why?
Diagnosis, Differential
1
2008
933
0.060
Why?
Sensitivity and Specificity
1
2008
1093
0.060
Why?
Minimally Invasive Surgical Procedures
1
2005
98
0.060
Why?
Cardia
1
2004
2
0.060
Why?
Proto-Oncogene Proteins p21(ras)
2
2017
55
0.060
Why?
Risk Assessment
2
2016
1920
0.060
Why?
Multivariate Analysis
3
2014
902
0.060
Why?
Severity of Illness Index
2
2008
1479
0.060
Why?
Cholecystectomy
1
2004
31
0.060
Why?
Evidence-Based Medicine
1
2006
442
0.060
Why?
Chemotherapy, Adjuvant
1
2003
75
0.050
Why?
Laser Therapy
1
2002
36
0.050
Why?
Laparoscopy
1
2005
426
0.050
Why?
Survival Analysis
3
2010
555
0.040
Why?
Feasibility Studies
2
2012
525
0.040
Why?
Prospective Studies
2
2017
3065
0.040
Why?
Epirubicin
1
2017
2
0.040
Why?
Leucovorin
1
2017
9
0.040
Why?
Margins of Excision
1
2017
24
0.040
Why?
Neoplasm, Residual
1
2017
38
0.040
Why?
Antineoplastic Agents
2
2017
631
0.030
Why?
Mice, Inbred Strains
1
2017
179
0.030
Why?
Young Adult
3
2012
4266
0.030
Why?
3' Untranslated Regions
1
2017
89
0.030
Why?
Anorexia
1
2016
6
0.030
Why?
Mutation
2
2017
2452
0.030
Why?
Celecoxib
1
2016
13
0.030
Why?
Chemotherapy-Induced Febrile Neutropenia
1
2016
3
0.030
Why?
Magnetic Resonance Imaging
1
2005
2059
0.030
Why?
Xenograft Model Antitumor Assays
1
2017
178
0.030
Why?
Camptothecin
1
2016
22
0.030
Why?
Deglutition Disorders
1
2016
41
0.030
Why?
Drug Administration Schedule
1
2016
283
0.030
Why?
Serpins
1
2015
17
0.030
Why?
Nausea
1
2016
110
0.030
Why?
Necrosis
1
2015
140
0.030
Why?
Administration, Oral
1
2016
356
0.030
Why?
Disease Management
1
2017
221
0.030
Why?
Genome-Wide Association Study
1
2017
331
0.030
Why?
Age of Onset
1
2014
170
0.030
Why?
Capecitabine
1
2013
10
0.030
Why?
Dose-Response Relationship, Radiation
1
2013
52
0.030
Why?
Drug Delivery Systems
1
2017
311
0.030
Why?
Radiation Injuries
1
2013
62
0.030
Why?
Cell Line, Tumor
1
2017
1368
0.030
Why?
Case-Control Studies
1
2016
1051
0.030
Why?
Effect Modifier, Epidemiologic
1
2012
9
0.030
Why?
Molecular Epidemiology
1
2012
25
0.030
Why?
Logistic Models
1
2016
1232
0.030
Why?
DNA, Neoplasm
1
2012
52
0.020
Why?
Cystadenoma, Serous
1
2012
4
0.020
Why?
Proto-Oncogene Proteins B-raf
1
2012
53
0.020
Why?
ras Proteins
1
2012
77
0.020
Why?
Ergonomics
1
2012
78
0.020
Why?
Learning Curve
1
2012
30
0.020
Why?
Algorithms
1
2017
976
0.020
Why?
Efficiency, Organizational
1
2012
94
0.020
Why?
Regression Analysis
1
2012
485
0.020
Why?
Comorbidity
1
2014
1078
0.020
Why?
Incidence
1
2014
1236
0.020
Why?
Nanoparticles
1
2017
493
0.020
Why?
Cells, Cultured
1
2015
2089
0.020
Why?
Dilatation, Pathologic
1
2010
29
0.020
Why?
Continuity of Patient Care
1
2012
170
0.020
Why?
Proto-Oncogene Proteins
1
2012
318
0.020
Why?
Occupational Health
1
2012
180
0.020
Why?
Mice, Knockout
1
2015
1985
0.020
Why?
DNA Methylation
1
2012
271
0.020
Why?
Constriction, Pathologic
1
2010
112
0.020
Why?
Medical Errors
1
2012
195
0.020
Why?
World Health Organization
1
2010
30
0.020
Why?
Probability
1
2010
166
0.020
Why?
Patient Care Team
1
2012
326
0.020
Why?
Chi-Square Distribution
1
2010
409
0.020
Why?
Analysis of Variance
1
2010
589
0.020
Why?
Pilot Projects
1
2012
914
0.020
Why?
Animals
2
2017
19601
0.020
Why?
Breast Neoplasms
1
2017
1118
0.020
Why?
Mice, Inbred C57BL
1
2015
3220
0.020
Why?
Communication
1
2012
546
0.020
Why?
Acute Disease
1
2008
659
0.020
Why?
Malignant Carcinoid Syndrome
1
2006
1
0.020
Why?
Respiratory Tract Neoplasms
1
2006
3
0.020
Why?
Registries
1
2010
801
0.020
Why?
Antineoplastic Agents, Hormonal
1
2006
30
0.020
Why?
Gastrointestinal Neoplasms
1
2006
31
0.020
Why?
Cohort Studies
1
2010
2372
0.010
Why?
Gastrectomy
1
2004
37
0.010
Why?
Diagnostic Imaging
1
2006
243
0.010
Why?
Biomarkers, Tumor
1
2006
461
0.010
Why?
Mice
1
2015
10251
0.010
Why?
Predictive Value of Tests
1
2004
1025
0.010
Why?
Swanson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (217)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_